May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Intravitreal Tumor Necrosis Factor-alpha Antisense-Oligonucleotides Improve Herpes Simplex Virus Induced Acute Retinitis
Author Affiliations & Notes
  • A. Heiligenhaus
    Department of Ophthalmology, St. Franziskus Hospital Muenster, Muenster, Germany
  • J. Li
    Department of Ophthalmology, St. Franziskus Hospital Muenster, Muenster, Germany
  • S. Wasmuth
    Department of Ophthalmology, St. Franziskus Hospital Muenster, Muenster, Germany
    Ophthalmology, University Duisburg-Essen, Essen, Germany
  • M. Hennig
    Department of Ophthalmology, St. Franziskus Hospital Muenster, Muenster, Germany
    Ophthalmology, University Duisburg-Essen, Essen, Germany
  • D. Bauer
    Department of Ophthalmology, St. Franziskus Hospital Muenster, Muenster, Germany
  • Footnotes
    Commercial Relationships A. Heiligenhaus, None; J. Li, None; S. Wasmuth, None; M. Hennig, None; D. Bauer, None.
  • Footnotes
    Support DFG Grants He 1877/12-2; Ba 2248/1-1 and Ernst and Berta Grimmke Foundation
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 737. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Heiligenhaus, J. Li, S. Wasmuth, M. Hennig, D. Bauer; Intravitreal Tumor Necrosis Factor-alpha Antisense-Oligonucleotides Improve Herpes Simplex Virus Induced Acute Retinitis. Invest. Ophthalmol. Vis. Sci. 2007;48(13):737.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: In the murine model of herpes simplex virus (HSV)-1 induced acute retinal necrosis (von Szily model), TNF-α is expressed in the contralateral eye during the development of disease. This study analyzed the influence of an intravitreal injection of antisense-oligonukleotides (ASON) directed against TNF-α mRNA on the contralateral retinitis.

Methods:: The distribution of FITC-labeled TNF-α-ASON was determined after intravitreal injection. Paraffin sections from eyes, regional lymph nodes (rln) and spleens were investigated by fluorescence microscopy, and single cell suspensions from rln and spleens were analyzed by flow cytometry. In BALB/c mice, 1x105 PFU of HSV-1 (KOS) were injected on day 0 into the anterior chamber of the right eyes. On day +7, TNF-α-ASON were injected into the vitreous of the contralateral eyes. Control-ASON (CON) or buffer were applied in control mice. The contralateral eyes were followed clinically for the presence of disease, and were studied by histopathology. In the contralateral eyes, intraocular TNF-α expression and virus replication were analyzed. The HSV-1-antigen specific DTH was determined on day +10.

Results:: Two days after intravitreal FITC-ASON injection, FITC-positive cells were found in the inner retina, ciliary body and iris. By flow cytometry analysis, few FITC-positive cells were found in the rln and spleen. Following the TNF-α-ASON injection in the contralateral eyes, the incidence and severity of retinitis, the inflammatory cell infiltration in the choroid and retina, and the intraocular TNF-α expression were reduced as compared to the control groups. The viral titers in the contralateral eyes and the HSV-1 specific DTH-reaction did not differ between the groups.

Conclusions:: TNF-α-ASON were found in retinal and uveal cells after intravitreal injection. The incidence and severity of experimental HSV-1 induced acute retinitis in the contralateral eyes improved after treatment, while the systemic immune response was not altered.

Keywords: retinitis • immunomodulation/immunoregulation • herpes simplex virus 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×